Kovitz Investment Group Partners, LLC Gilead Sciences, Inc. Transaction History
Kovitz Investment Group Partners, LLC
- $28.6 Billion
- Q4 2024
A detailed history of Kovitz Investment Group Partners, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Kovitz Investment Group Partners, LLC holds 36,342 shares of GILD stock, worth $3.91 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
36,342
Previous 36,342
-0.0%
Holding current value
$3.91 Million
Previous $3.36 Million
-0.0%
% of portfolio
0.01%
Previous 0.01%
Shares
27 transactions
Others Institutions Holding GILD
# of Institutions
2,101Shares Held
1.02BCall Options Held
8.73MPut Options Held
9.63M-
Black Rock Inc. New York, NY121MShares$13 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA116MShares$12.4 Billion0.19% of portfolio
-
Capital World Investors Los Angeles, CA71.7MShares$7.71 Billion1.05% of portfolio
-
State Street Corp Boston, MA60.4MShares$6.49 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA57.9MShares$6.23 Billion1.15% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $135B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...